But you were suggesting that we cannot look at the efficacy of mixed doses, being compelling...... why not. The answer is in case 1 donor, or 2 donors' cells do not work, and only 1 or 2 of the 3 donors have cells that actually works.
Look at the evidence from the single donor, the mixed donors.... is there a different result? Did Bour an Klinker get different results from their 6 lines of lab testing? Is the company saying.... only cells from this 1 person, 2 or 3 people actually work?
You are suggesting it's a posibility.... one so great it's worth non approval?
MSB Price at posting:
93.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)